Lung cancer is a complex disease, accounting for almost 25% of all cancer deaths. The Food and Drug Administration (FDA) has approved Rybrevant for treatment of adults with non-small cell lung cancer…
Category: Lung Cancer Treatment
Get to know about types of lung cancer treatment methods, causes, researches, early symptoms and stages. To know more details about the lung cancers browse the website.
Topotecan–Berzosertib Combination Effective for SCLC Treatment
Researchers all over the world are continuously been working towards finding effective treatments and therapies for lung cancer. There are widely two types of lung cancer: small cell lung cancer (SCLC) and…
FDA Approves Libtayo as Monotherapy for Advanced NSCLC
Lung cancer is one of the leading causes of cancer-related deaths worldwide. In the year 2020, an estimated 225,000 new cases were diagnosed in the United States. Also, approximately 84% of all…
Study Says Deep Learning May Help Choose Better Lung Cancer Treatments
According to a study published in the International Journal of Medical Informatics, a deep learning tool was able to accurately predict the survival expectancy in lung cancer patients. This potentially helps in…
NICE Recommends Keytruda Plus Chemo for NSCLC Treatment
National Institute for Health and Care Excellence (NICE) has recommended Keytruda, alongside a combination of pemetrexed and platinum chemotherapy for first-line treatment of non-small cell lung cancer (NSCLC). This combination is recommended…
Study on New Combination of Immunotherapy Shows Promising Lung Cancer Treatment
In a recent study, researchers have established that a novel combination of two forms of immunotherapy can be highly effective in treatment of lung cancer. This new treatment uses one form of…
Lovelace Biomedical Provides New Formulation for Lung Cancer Treatment
Lung Cancer is a deadly disease taking away lives of hundreds of people every year. More and more studies and researches are being conducted in the arena for treatment of lung cancer….
Early Treatment with Lorlatinib Helps in Improving Lung Cancer Survival Rate
Non-small cell lung cancer accounts for 87% of all lung cancer cases and some 5% of NSCLC cases are ALK-positive. This implies that they have genetic abnormality in the anaplastic lymphoma kinase…
Post-Surgical Lung Cancer Treatments
Surgery is the treatment option for patients with non-small cell lung cancer. It might be the best option as it provides high chances of curing the disease. But, as lung cancer surgery…
Proton Therapy for Lung Cancer May Help Prevent Heart Disease
Proton therapy for lung cancer treatment is a reasonable treatment for patients whose cancer is limited to the chest. The physicians are able to deliver highly effective and precise doses of protons…
Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that treatment ineffective. The researchers at Moffitt Cancer Center…
New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is called Tecentriq or atezolizumab. It…